BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1104 related articles for article (PubMed ID: 33573368)

  • 1. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
    Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
    Brkic M; Balusu S; Libert C; Vandenbroucke RE
    Mediators Inflamm; 2015; 2015():620581. PubMed ID: 26538832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
    Rosenberg GA
    Lancet Neurol; 2009 Feb; 8(2):205-16. PubMed ID: 19161911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System.
    Carpanini SM; Torvell M; Morgan BP
    Front Immunol; 2019; 10():362. PubMed ID: 30886620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.
    Leppert D; Lindberg RL; Kappos L; Leib SL
    Brain Res Brain Res Rev; 2001 Oct; 36(2-3):249-57. PubMed ID: 11690622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifaceted role of matrix metalloproteinases (MMPs).
    Singh D; Srivastava SK; Chaudhuri TK; Upadhyay G
    Front Mol Biosci; 2015; 2():19. PubMed ID: 25988186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases.
    Huang J; Huang N; Xu S; Luo Y; Li Y; Jin H; Yu C; Shi J; Jin F
    J Nutr Biochem; 2021 Feb; 88():108552. PubMed ID: 33220405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Matrix Metalloproteinases in the Pathogenesis of Traumatic Brain Injury.
    Abdul-Muneer PM; Pfister BJ; Haorah J; Chandra N
    Mol Neurobiol; 2016 Nov; 53(9):6106-6123. PubMed ID: 26541883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain.
    Gasche Y; Soccal PM; Kanemitsu M; Copin JC
    Front Biosci; 2006 May; 11():1289-301. PubMed ID: 16368516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of matrix metalloproteinases in regulating neuronal disorder.
    Mukherjee A; Swarnakar S
    Mol Biol Rep; 2015 Jan; 42(1):1-11. PubMed ID: 25374425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models.
    Sugama S; Takenouchi T; Cho BP; Joh TH; Hashimoto M; Kitani H
    Inflamm Allergy Drug Targets; 2009 Sep; 8(4):277-84. PubMed ID: 19754411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural products as a potential modulator of microglial polarization in neurodegenerative diseases.
    Jin X; Liu MY; Zhang DF; Zhong X; Du K; Qian P; Gao H; Wei MJ
    Pharmacol Res; 2019 Jul; 145():104253. PubMed ID: 31059788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.
    Rivera S; García-González L; Khrestchatisky M; Baranger K
    Cell Mol Life Sci; 2019 Aug; 76(16):3167-3191. PubMed ID: 31197405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Curcumin on Microglial Cells.
    Ghasemi F; Bagheri H; Barreto GE; Read MI; Sahebkar A
    Neurotox Res; 2019 Jul; 36(1):12-26. PubMed ID: 30949950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion channels on microglia: therapeutic targets for neuroprotection.
    Skaper SD
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there new hope for therapeutic matrix metalloproteinase inhibition?
    Vandenbroucke RE; Libert C
    Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review.
    Dailah HG
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A friend in need may not be a friend indeed: role of microglia in neurodegenerative diseases.
    Kaushik DK; Basu A
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):726-40. PubMed ID: 24070095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How neuroinflammation contributes to neurodegeneration.
    Ransohoff RM
    Science; 2016 Aug; 353(6301):777-83. PubMed ID: 27540165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on the Role of Matrix Metalloproteinases in the Pathogenesis of Multiple Sclerosis.
    Boziki M; Grigoriadis N
    Med Chem; 2018 Feb; 14(2):155-169. PubMed ID: 28875862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.